Symbol Lookup

Friday December 09, 2016 11:54 PM ET. Data delayed 15 minutes.
6.94
0.04 (0.58%)
Bid/Lots
0.00/0
Ask/Lots
0.00/0
Open/Prev Close
6.91/6.90
Day Range
6.65-7.01
52-Week Range
5.76-13.68
Vol/Avg Daily Vol
136.9K/183.6K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
European ADRs Edge Lower Despite Banking Gains
10:35AM ET on Monday Nov 14, 2016 by MT Newswires
10:35 AM EST, 11/14/2016 (MT Newswires) -- American depository receipts of European stocks were 0.9% lower at 115.14 on the Bank of New York Mellon Europe ADR Index on Monday morning. Decliners in Continental Europe were led by CGG (CGG), a manu...

Company Information

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

CONTACT INFORMATION

HeadquartersIDA Business Park
BRAY, Ireland 18
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$165.3MBeta1.17
Revenue (TTM)$100.9MEPS$0.07
Shares Out.24.0MBook Value$8.93
Dividend Yield0.00%P/E93.8x
Annual Dividend Rate0.00 USDPrice/Sales (TTM)1.6
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin9.94%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample